Subtopic Deep Dive

← Protein Kinase Regulation and GTPase Signaling

Protein Kinase C Signaling
Research Guide

What is Protein Kinase C Signaling?

Protein Kinase C (PKC) signaling refers to the activation of PKC isoforms by diacylglycerol (DAG) and calcium ions, transducing extracellular signals to regulate Ca2+-dependent cellular processes including proliferation, migration, and apoptosis.

PKC enzymes, discovered by Nishizuka, activate via receptor-mediated hydrolysis of inositol phospholipids producing DAG and IP3 (Nishizuka, 1986, 5133 citations). Multiple isoforms exist with roles in signal transduction and tumor promotion (Nishizuka, 1984, 7521 citations). Over 10 key papers from 1984-2007 detail activation mechanisms and inhibitors like GF 109203X (Toullec et al., 1991, 2481 citations).

Curated Papers

Key Challenges

Why It Matters

PKC signaling drives cell proliferation and tumor promotion, making it a target for cancer therapies (Nishizuka, 1984). Dysregulated PKC contributes to inflammation and apoptosis resistance, with inhibitors like GF 109203X showing selectivity for PKC over other kinases (Toullec et al., 1991). Berridge's work on IP3 and DAG as second messengers links PKC to broader phosphoinositide pathways influencing MAPK signaling (Berridge, 1984; Alessi et al., 1995). Pharmacological modulation, profiled in Bain et al. (2007, 2489 citations), guides drug development for PKC-related diseases.

Key Research Challenges

Isoform-Specific Activation

Distinguishing activation mechanisms among PKC isoforms by DAG and calcium remains difficult due to overlapping substrates. Nishizuka (1986) notes variable Ca2+ dependencies across isoforms. Selective inhibitors like GF 109203X help but lack full specificity (Toullec et al., 1991).

Dysregulation in Cancer

PKC upregulation promotes tumor growth, complicating therapeutic targeting without off-target effects. Nishizuka (1984) links PKC to tumor promotion via signal transduction. Profiling 65 inhibitors reveals cross-reactivity issues (Bain et al., 2007).

Second Messenger Integration

Integrating PKC with IP3/DAG pathways and downstream MAPK requires clarifying crosstalk. Berridge and Irvine (1984) identified IP3 as a Ca2+ mobilizer for PKC. Alessi et al. (1995) show MAPK inhibitors like PD 098059 indirectly affect PKC pathways.

Essential Papers

The role of protein kinase C in cell surface signal transduction and tumour promotion

Yasutomi Nishizuka · 1984 · Nature · 7.5K citations

Inositol trisphosphate, a novel second messenger in cellular signal transduction

Michael J. Berridge, Robin F. Irvine · 1984 · Nature · 6.1K citations

Studies and Perspectives of Protein Kinase C

Yasutomi Nishizuka · 1986 · Science · 5.1K citations

Protein kinase C, an enzyme that is activated by the receptor-mediated hydrolysis of inositol phospholipids, relays information in the form of a variety of extracellular signals across the membrane...

Inositol trisphosphate and diacylglycerol as second messengers

Michael J. Berridge · 1984 · Biochemical Journal · 3.5K citations

Research Article| June 01 1984 Inositol trisphosphate and diacylglycerol as second messengers M J Berridge M J Berridge Search for other works by this author on: This Site PubMed Google Scholar Bio...

PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo

Dario R. Alessi, Ana Cuenda, Philip Cohen et al. · 1995 · Journal of Biological Chemistry · 3.4K citations

PD 098059 has been shown previously to inhibit the dephosphorylated form of mitogen-activated protein kinase kinase-1 (MAPKK1) and a mutant MAPKK1(S217E,S221E), which has low levels of constitutive...

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

Wei Zhang, Hui-Tu Liu · 2002 · Cell Research · 2.8K citations

Signaling—2000 and Beyond

Tony Hunter · 2000 · Cell · 2.6K citations

Reading Guide

Foundational Papers

Start with Nishizuka (1984, 7521 citations) for PKC's role in signal transduction and tumor promotion; follow with Nishizuka (1986, 5133 citations) for isoform perspectives and Berridge (1984, 3528 citations) for DAG/IP3 mechanisms.

Recent Advances

Bain et al. (2007, 2489 citations) profiles inhibitor selectivity; Toullec et al. (1991, 2481 citations) details GF 109203X; Alessi et al. (1995, 3421 citations) links to MAPK inhibition.

Core Methods

Phospholipid hydrolysis assays for DAG/IP3 (Berridge, 1984); kinase activity assays with Ca2+ (Nishizuka, 1986); inhibitor profiling against kinase panels (Bain et al., 2007; Toullec et al., 1991).

How PapersFlow Helps You Research Protein Kinase C Signaling

Discover & Search

Research Agent uses searchPapers and citationGraph on Nishizuka (1984, 7521 citations) to map PKC signaling's influence across 250M+ OpenAlex papers, revealing connections to tumor promotion. exaSearch finds recent isoform studies; findSimilarPapers expands from Berridge (1984) to DAG pathways.

Analyze & Verify

Analysis Agent applies readPaperContent to extract activation details from Nishizuka (1986), then verifyResponse with CoVe for accurate DAG/Ca2+ claims. runPythonAnalysis plots inhibitor IC50 data from Toullec et al. (1991) using pandas; GRADE grades evidence on isoform selectivity (Bain et al., 2007).

Synthesize & Write

Synthesis Agent detects gaps in isoform-specific inhibitors via contradiction flagging across Nishizuka papers. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Alessi et al. (1995), with latexCompile for publication-ready output; exportMermaid visualizes PKC-MAPK pathways.

Use Cases

"Analyze PKC inhibitor selectivity from key papers using Python."

Research Agent → searchPapers('PKC inhibitors') → Analysis Agent → readPaperContent(Toullec 1991) + runPythonAnalysis(pandas plot IC50 vs kinases) → matplotlib graph of GF 109203X specificity.

"Write LaTeX review on PKC activation by DAG and IP3."

Synthesis Agent → gap detection(Nishizuka 1986, Berridge 1984) → Writing Agent → latexEditText(draft section) → latexSyncCitations(10 papers) → latexCompile(PDF with PKC pathway figure).

"Find code for PKC signaling simulations from papers."

Research Agent → searchPapers('PKC signaling model') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → exportCsv(models for DAG kinetics).

Automated Workflows

Deep Research workflow scans 50+ PKC papers via searchPapers → citationGraph(Nishizuka hub) → structured report on isoform roles. DeepScan's 7-step chain with CoVe verifies inhibitor claims from Bain et al. (2007). Theorizer generates hypotheses on PKC-MAPK crosstalk from Alessi et al. (1995).

Try Doxa for Protein Kinase C Signaling Research

Frequently Asked Questions

What defines Protein Kinase C signaling?

PKC signaling is the DAG- and Ca2+-dependent activation of PKC isoforms transducing signals for proliferation and apoptosis (Nishizuka, 1986).

What are key methods in PKC studies?

Receptor-mediated phospholipid hydrolysis produces DAG/IP3 for PKC activation; inhibitors like GF 109203X test selectivity (Toullec et al., 1991; Berridge, 1984).

What are foundational PKC papers?

Nishizuka (1984, 7521 citations) on tumor promotion; Nishizuka (1986, 5133 citations) on perspectives; Berridge and Irvine (1984, 6105 citations) on IP3.

What open problems exist in PKC signaling?

Isoform-specific targeting amid cross-reactivity (Bain et al., 2007); integrating with MAPK pathways (Alessi et al., 1995); cancer-specific dysregulation mechanisms.